Former FDA head Gottlieb comes out against RFK Jr. for HHS news2024-12-02T18:15:00+00:00December 2nd, 2024|Endpoints News|
Biocon lands FDA approval for another Stelara biosimilarnews2024-12-02T18:11:06+00:00December 2nd, 2024|Endpoints News|
Applied Therapeutics’ rare disease drug gets a CRLnews2024-11-27T22:15:08+00:00November 27th, 2024|Endpoints News|
FDA is looking into hematology risks after patients take Bluebird’s Skysona gene therapynews2024-11-27T19:44:30+00:00November 27th, 2024|Endpoints News|
PTC reports Phase 2 ALS fail, sells priority review voucher for $150Mnews2024-11-27T13:35:17+00:00November 27th, 2024|Endpoints News|
Trump picks Stanford academic and pandemic critic Bhattacharya for NIHnews2024-11-27T03:39:30+00:00November 27th, 2024|Endpoints News|
The Biden administration wants Medicare and Medicaid to cover GLP-1s. Will the Trump White House allow it?news2024-11-26T21:09:00+00:00November 26th, 2024|Endpoints News|
Axsome moves toward NDA filing for narcolepsy drug after Phase 3 datanews2024-11-26T18:41:00+00:00November 26th, 2024|Endpoints News|
Soleno’s rare pediatric disease drug faces PDUFA delay by three monthsnews2024-11-26T16:02:30+00:00November 26th, 2024|Endpoints News|
Trump team asked Covid vaccine leader about heading NIHnews2024-11-25T19:37:14+00:00November 25th, 2024|Endpoints News|
